- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/20 - Pills, lozenges or tablets
Patent holdings for IPC class A61K 9/20
Total number of patents in this class: 14454
10-year publication summary
|
1257
|
1176
|
1293
|
1282
|
1262
|
1105
|
1056
|
1028
|
1073
|
319
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10345 |
145 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 295 |
141 |
| Fertin Pharma A/S | 273 |
125 |
| Antecip Bioventures II LLC | 360 |
109 |
| Boehringer Ingelheim International GmbH | 4510 |
97 |
| Axsome Therapeutics, Inc. | 330 |
94 |
| Takeda Pharmaceutical Company Limited | 2721 |
84 |
| ratiopharm GmbH | 295 |
80 |
| Synthon BV | 310 |
80 |
| Daiichi Sankyo Company, Limited | 1888 |
75 |
| Gilead Sciences, Inc. | 2186 |
73 |
| Purdue Pharma L.P. | 494 |
72 |
| Merck Patent GmbH | 5663 |
70 |
| Hanmi Pharm. Co., Ltd. | 593 |
70 |
| Vertex Pharmaceuticals Incorporated | 1601 |
64 |
| AstraZeneca AB | 2837 |
62 |
| Novo Nordisk A/S | 2302 |
62 |
| Hoffmann-La Roche Inc. | 3696 |
61 |
| Astellas Pharma Inc. | 1030 |
54 |
| Lupin Limited | 430 |
53 |
| Other owners | 12783 |